Abstract

Gene plasticity during myogenous temporomandibular disorder (TMDM) development is largely unknown. TMDM could be modeled by intramuscular inflammation or tissue damage. To model inflammation induced TMDM we injected complete Freund’s adjuvant (CFA) into masseter muscle (MM). To model tissue damage induced TMDM we injected extracellular matrix degrading collagenase type 2 (Col). CFA and Col produced distinct myalgia development trajectories. We performed bulk RNA-seq of MM to generate gene plasticity time course. CFA initiated TMDM (1d post-injection) was mainly linked to chemo-tacticity of monocytes and neutrophils. At CFA-induced hypersensitivity post-resolution (5d post-injection), tissue repair processes were pronounced, while inflammation was absent. Col (0.2U) produced acute hypersensitivity linked to tissue repair without inflammatory processes. Col (10U) generated prolonged hypersensitivity with inflammatory processes dominating initiation phase (1d). Pre-resolution phase (6d) was accompanied with acceleration of expressions for tissue repair and pro-inflammatory genes. Flow cytometry showed that immune processes in MM was associated with accumulations of macrophages, natural killer, dendritic and T-cells, further confirming our RNA-seq findings. Altogether, CFA and Col treatments induced different immune processes in MM. Importantly, TMDM resolution was preceded with muscle cell and extracellular matrix repairs, an elevation in immune system gene expressions and distinct immune cell accumulations in MM.

Details

Title
Associations of tissue damage induced inflammatory plasticity in masseter muscle with the resolution of chronic myalgia
Author
Lindquist, Karen A. 1 ; Shein, Sergey A. 2 ; Hovhannisyan, Anahit H. 3 ; Mecklenburg, Jennifer 3 ; Zou, Yi 4 ; Lai, Zhao 5 ; Tumanov, Alexei V. 6 ; Akopian, Armen N. 7 

 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The School of Medicine, UTHSCSA, Departments of Microbiology, Immunology & Molecular Genetics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The School of Dentistry, The University of Texas Health Science Center at San Antonio (UTHSCSA), Departments of Endodontics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The School of Medicine, UTHSCSA, Departments of Molecular Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The School of Medicine, UTHSCSA, Departments of Molecular Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); Greehey Children’s Cancer Research Institute, UTHSCSA, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); The School of Medicine, UTHSCSA, Departments of Microbiology, Immunology & Molecular Genetics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); The School of Dentistry, The University of Texas Health Science Center at San Antonio (UTHSCSA), Departments of Endodontics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
Pages
22057
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2900962822
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.